Dec 21
|
Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia
|
Dec 6
|
Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea
|
Nov 29
|
Incannex Healthcare Announces Completion of its Redomiciliation to the United States
|